SELLAS Life Sciences Group, Inc. (SLS)
11.74
+0.41
(+3.62%)
USD |
NASDAQ |
Oct 02, 16:00
11.75
+0.01
(+0.09%)
After-Hours: 20:00
SELLAS Life Sciences Group Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2022 | -1.67K% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | -242.8% |
| March 31, 2021 | -42.16% |
| December 31, 2020 | -195.6% |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 |
| Date | Value |
|---|---|
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | |
| June 30, 2015 | -463.0% |
| March 31, 2015 | -383.2% |
| December 31, 2014 | -249.0% |
| September 30, 2014 | -381.0% |
| June 30, 2014 | -855.5% |
| March 31, 2014 | -116.7% |
| December 31, 2013 | -3.68K% |
| September 30, 2013 | -793.8% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| AbbVie, Inc. | 21.21% |
| Capricor Therapeutics, Inc. | -- |
| Alnylam Pharmaceuticals, Inc. | 12.74% |
| Incyte Corp. | 34.98% |
| Insmed, Inc. | -3.11% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -41.86% |
| Return on Assets | -38.48% |
| Return on Invested Capital | -41.44% |
| Return on Net Operating Assets | -497.5% |